Tasiamide

General Information


DRACP ID  DRACP04199

Peptide Name   Tasiamide

Sequence  LXIGxP

Sequence Length  6

UniProt ID  Not available

PubChem CID  Not available

Origin  Bacteria

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  2-OH-ME-C5

C-terminal Modification  OMe

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C19H30N4O3

Absent amino acids  ACDEFHKMNQRSTVWY

Common amino acids  GILPX

Mass  56184

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  2

Net charge  0

Boman Index  1078

Hydrophobicity  105

Aliphatic Index  130

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 12350160

Title  Tasiamide, a cytotoxic peptide from the marine cyanobacterium Symploca sp

Doi Not available

Year  2002

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  18461

DRACP is developed by Dr.Zheng's team.